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Aim of the database: The aim of the Danish Adult Diabetes Registry (DADR) is to provide 
data from both the primary health care sector (general practice [GP]) and the secondary sector 
(specialized outpatient clinics) to assess the quality of treatment given to patients with diabetes. 
The indicators represent process and outcome indicators selected from the literature.
Study population: The total diabetes population in Denmark is estimated to be ∼300,000 
adult diabetes patients. Approximately 10% have type 1 diabetes, which is managed mainly in 
the secondary sector, and 90% have type 2 diabetes with the majority (80%) being treated in 
primary health care. In 2014, DADR included data from a total of 70,826 patients.
Main variables: The following variables are assessed: date of analysis as well as the outcome 
for hemoglobin A1c, blood pressure, lipids, urinary albumin–creatinine ratio, smoking status, 
glucose-, blood pressure-, and lipid-lowering treatment (yes/no), insulin pump treatment (yes/
no), and date of last eye and foot examination.
Descriptive data: In 2014, the annual report included data regarding over 38,000 patients 
from outpatient clinics, which is assumed to have included almost all patients in this setting, 
and .32,000 from GPs, reflecting improved but still limited coverage from this setting. The 
annual results are published in a compiled report of Danish Diabetes Care, which included 
DADR, data from the pediatric diabetes database, and the national ophthalmological diabetes 
database. The annual report is published, which included data on national, regional, and local 
level (individual outpatient clinics and corresponding GPs). This allows a comprehensive over-
view of diabetes care in Denmark.
Conclusion: The database covers an increasing fraction of patients with diabetes in Denmark, 
and the structure for full coverage is in place. Annual reporting has helped to ensure focus on 
the quality of diabetes treatment in the primary and secondary health care. Furthermore, it is 
an important resource for Danish register-based diabetes research.
Keywords: diabetes, national registry, epidemiology, quality of care
Background
Diabetes is a widespread chronic disease with .300,000 patients in Denmark. 
Approximately 10% have type 1 diabetes, which is managed primarily in outpatient 
clinics, and 90% have type 2 diabetes, among whom the majority (80%) are treated 
in primary health care.
The treatment has evolved in recent decades, with better options for education, 
self-care, and individualized insulin treatment with pens and pumps, focus on multi-
factorial intervention including lifestyle modification, and control of glucose, blood 
pressure, and lipids. As a result, the prognosis for patients has improved considerably 
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regarding the development of micro- and macrovascular 
complications and survival.1–5 Structured care with regular 
screening for complications and targeted intervention has 
been important for this development.
Aim
Quality monitoring is necessary to ensure that patients with 
type 1 and type 2 diabetes in Denmark benefit from current 
improvements in care, and are treated according to nationally 
agreed treatment guidelines. The aim of the Danish Adult 
Diabetes Registry (DADR) (initially The National Indicator 
Project for Diabetes) is to provide data from both the primary 
health care sector (general practice [GP]) and the secondary 
sector (specialized outpatient clinics) to assess the quality 
of treatment given to patients with diabetes, with respect to 
selected well-documented and treatment-relevant process 
and result indicators. The registry has published an annual 
report since 2005.
Study population
All diabetes outpatient clinics have had an obligation to report 
to the database since 2004, data from the GPs were included 
from 2006, and inclusion became mandatory from 2014. The 
reporting is done through various information technology 
systems ranging from manual data entry from paper records 
to automated data capture from electronic patient records.
As .80% of patients with type 2 diabetes are taken care 
of by GPs, the reporting from primary care to the DADR has 
been a very important and unique feature, compared to most 
other registries relying on secondary health care data.
Main variables and quality 
indicators
National evidence-based guidelines for treatment and con-
trol have been developed to guide clinicians toward optimal 
treatment for all patients.6,7 Furthermore, disease manage-
ment programs, defined as the total cross-disciplinary, 
multi sectoral, and coordinated health care services for 
a given chronic condition, have been evolved to create a 
framework that ensures the application of evidence-based 
recommendations for health care intervention, including a 
precise  description of tasks and coordination between all 
parties involved.
To ensure the indicators are perceived as relevant and 
meaningful for reporting GPs and hospital units, indicators 
have been selected for quality assessment, covering aspects 
of cardiometabolic control and complication-screening 
activity. To reduce burden of reporting results, the number 
of variables initially had to be limited. Selection of indicators 
has been based on the following criteria: 1) a strong associa-
tion with disease progression and prognosis, 2) standardized 
measurability, and 3) comparability across reporting units. 
Consequently, indicators of, for example, lifestyle, such as 
diet and physical activity, have so far been opted out, due to 
lack of a standardized tool for monitoring in clinical practice. 
Besides basic information on age, sex, and year of diabetes 
diagnosis, the following variables are reported annually to 
the DADR: glycated hemoglobin A1c (HbA1c), blood pres-
sure, lipids, urinary albumin–creatinine ratio, estimated 
glomerular filtration rate, body mass index, smoking status, 
glucose-, blood pressure-, and lipid-lowering treatment (yes/
no), insulin pump treatment (yes/no), date of last eye exami-
nation result known by the treating physician, and date of last 
foot examination. For each indicator, the steering committee 
for the database has agreed on a standard that the program 
should aim to reach. Figures 1 and 2 present the development 
in completeness over time for selected variables.
Derived process indicators and standards include:
•	 Annual measurement of HbA1c with a standardized 
method in 95% of patients
•	 Annual measurement of blood pressure in 95% of 
patients
•	 Measurement of lipids every second year in 90% of 
patients
•	 Foot examination in 95% of patients within 2 years
•	 Examination of urinary albumin–creatinine ratio in 95% 
of patients within 2 years
•	 Eye examination within a 2-year period in 90% of patients 
and within a 4-year period in 95% of patients
•	 Prescribed antidiabetic treatment among patients with 
HbA1c $53 mmol/mol (no standard decided upon yet)
•	 Prescribed antihyptertensive treatment among patients 
with blood pressure $140/90 mmHg (standard 80%)
•	 Prescribed lipid-lowering medication among patients 
with low-density lipoprotein cholesterol .2.5 mmol/L 
(no standard decided upon yet)
•	 Prescribed renin–angiotensin system blockade among 
patients with micro- or macroalbuminuria (no standard 
decided upon yet)
In the annual report, the indicators are presented sepa-
rately for primary and secondary health care on a national, 
regional, and local level (with primary care data shown for 
clusters referring to the same outpatient clinic). In addition, 
each outpatient clinic or GP has access to their own quality 
data. This allows a comprehensive overview of diabetes care 
in Denmark. Table 1 presents an example of the data.
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Follow-up
It is an ongoing focus to ensure valid data. Validity is 
evaluated and discussed on regional and national audits, and 
when compared to other registries of patients in outpatient 
clinics in Denmark, it is estimated that the data coverage is 
97% in 2014. Figure 1, 2, and 3 presents the development 
over time. Particularly in the beginning of the project, it has 
been a challenge. Currently, it is estimated that data com-
pleteness from the outpatient clinics, matching data to the 
administrative data in the Danish National Patient Register 
80
2008/09 2009/10 2010/11 2011/12
Calendar year
2012/13 2013/14 2014/15
Type 1, hospital
Type 2, hospital
Type 2, GP
82
84
86
88
90%
92
94
96
98
100
Figure 1 Change in completeness for reporting of HbA1c values over time.
Notes: The figure shows that change was measured and reported for the majority of patients. Technical problems with reporting were expected to be responsible for the 
2010/11 drop.
Abbreviations: HbA1c, hemoglobin A1c; GP, general practice.
2008/09 2009/10 2010/11 2011/12
Calendar year
2012/13 2013/14 2014/15
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84
86
88
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94
96
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100
Figure 2 Change in completeness for reporting of smoking habits over time.
Notes: The figure shows that change was measured and reported for an increasing number of patients in outpatient clinics, and is now high in both primary and secondary 
health care settings.
Abbreviation: GP, general practice.
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on all hospital contacts, is up to 95%. Furthermore, the setup 
has proved to be able to capture data from all outpatient clin-
ics, and all GPs. Approximately 10% of the data are entered 
manually into a data system, whereas the remaining 90% are 
captured directly from the electronic medical record systems, 
which minimize risk of data entry errors.
Unfortunately, uncertainty regarding data security and 
database approvals has stopped delivery of data from the GPs 
since September 2014, affecting primarily completeness of 
data regarding type 2 diabetes.
The annual 2014 report included data regarding over 
38,000 patients from outpatient clinics, which is assumed 
to have included almost all patients in this setting, and 
.32,000 from GPs (collected before September 2014). The 
annual results are published in a compiled report of Danish 
Diabetes Care, which included DADR, data from the pedi-
atric diabetes database, and the national ophthalmological 
diabetes database.1
The reported results are discussed at annual meetings. 
At the national audit, the indicators and standards for good 
clinical practice and care for patients with diabetes are dis-
cussed, and recommendations are agreed upon. In case of 
outlier results, local audit is recommended. The final report, 
including recommendations for improvement, is published 
online at https://www.sundhed.dk.8
Use of the database for research
The nationwide reporting of unbiased, valid, and standardized 
information to the registry makes it attractive for research 
purposes. The unique Danish personal identification number 
allows linkage at the individual level of the database with 
other Danish registers, for example, the National Patient 
Register and the cause of death register, offering opportuni-
ties to study differences in treatment and control across geo-
graphical and other specified subpopulations. For example, 
the DADR has been used for follow-up of the Danish Centre 
for Strategic Research in Type 2 Diabetes (DD2) cohort for 
information about prescription of antidiabetic therapies in 
newly diagnosed diabetes.9 Another epidemiological study 
has linked information from the DADR with information 
from the Danish Civil Registration System on country of 
origin. In a research field where longitudinal data were 
lacking, this study demonstrated a higher incidence of most 
micro- and macrovascular complications among migrants 
with diabetes from Sub-Saharan Africa, Middle East, and 
Asia compared to Danish born. These ethnic differences 
Table 1 Foot examination within a 2-year period
Proportion of diabetes patients receiving a foot examination within a 2-year period
Region Std met? Nominator/ 
denominator
Unknown  
(%)
Current year Earlier years
March 1, 2014–February 
28, 2015
2013/14 2012/13
Prop 95% CI Prop Prop
Hospital units,  
total
Yes 36,504/38,350 0 (0) 95 95–95 96 96
Capital Region of  
Denmark
Yes 13,549/14,300 0 (0) 95 94–95 94 95
Region Zealand Yes 4,221/4,359 0 (0) 97 96–97 97 93
Region of  
Southern Denmark
Yes 10,119/10,334 0 (0) 98 98–98 98 98
Central Denmark 
Region
Yes 5,833/6,151 0 (0) 95 94–95 96 96
North Denmark  
Region
No 2,782/3,206 0 (0) 87 86–88 92 92
General practices,  
total
No 24,823/32,128 0 (0) 77 77–78 81 85
Capital Region of Denmark No 7,082/9,210 0 (0) 77 76–78 81 86
Region Zealand No 4,160/5,436 0 (0) 77 75–78 79 83
Region of  
Southern Denmark
No 5,248/6,697 0 (0) 78 77–79 84 88
Central Denmark  
Region
No 5,991/7,769 0 (0) 77 76–78 80 83
North Denmark  
Region
No 2,342/3,016 0 (0) 78 76–79 82 88
Abbreviations: Std, standard; Prop, proportion; CI, confidence interval.
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persisted after adjustment for a wide range of confounders, 
including HbA1c, blood pressure, lipids, body mass index, 
smoking, diabetes duration, age, and sex.10
The number of published studies based on the registry is 
still limited, probably reflecting initial concerns about data 
validity and coverage. As these concerns have been resolved, 
there has been a steady increase in applications for data, and 
as the coverage of the patient population and duration of 
follow-up increases, the database will provide a valuable data 
source for Danish register-based diabetes research.
Administrative issues and funding
During the past decade, reporting has been increasingly 
automated and valid. However as mentioned, a recent dis-
cussion on data protection agreements has stopped data 
delivery from GPs. As the majority of patients are seen by 
GPs, an overview of diabetes care in Denmark will be far 
from complete without these data, so it is crucial that data 
will soon again be reported.
The registry is funded by the Danish Regions and adminis-
tered by the Danish Clinical Registries (Regionernes Kliniske 
Kvalitetsudviklings Program) that constitute the infrastructure 
of the national clinical quality databases in Denmark.
The registry is run by a steering committee with represen-
tatives both from the secondary and the primary sector from 
the five regions, and from the Danish Diabetes Association.
Conclusion
The database has helped significantly to ensure the quality of 
diabetes treatment in the primary and secondary health care 
sector in Denmark and can continue to do so if data from 
the GPs are included again. Furthermore, it is an important 
resource for Danish register-based diabetes research.
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